跳至主要内容
临床试验/NCT01551875
NCT01551875已完成不适用

A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors in Asymptomatic Nationwide Indian Population (SCORE India)

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,200
试验地点
1
主要终点
CIMT values in centimeters (unit) of male and female subjects without established cardiovascular disease.

研究概览

简要总结

This non-interventional, prospective, multi-centric, cross-sectional study is aimed to obtain the distribution of measurements of CIMT in Indian subjects and will involve approx. 30 investigative sites from all over the country. Each investigative site will be expected to enrol 50 subjects and Carotid intima-media thickness (CIMT) values will be taken for each individual as described in the protocol.

All the procedures could be completed in a single day, however due to any reason any study variable is not taken subject may be asked to come back for a second visit within 7 days of the first visit.

详细描述

A Study to derive normative distribution of CIMT and to determine its cOrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population. (SCORE India)

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of subject informed consent
  • Female or male aged 30 years and over

排除标准

  • Subjects with established cardiovascular event
  • Intake of lipid lowering drug in the past 3 month
  • Subjects with known hypersensitivity to carotid bulb
  • Pregnant or lactating women

结局指标

主要结局

CIMT values in centimeters (unit) of male and female subjects without established cardiovascular disease.

时间窗: at visit 1

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验